Ahlers, Silke

• Volume 30, No 3 (2017) - Original Articles
  Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study
  Abstract  PDF  HTML  Fig 2b  Fig 1a  Fig 1b  Fig 2a  Fig 2c  Fig 2d  Supplementary tables  Untitled  response to reviewers